Evaluation of a Multidisciplinary Care Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease

Active, not recruitingOBSERVATIONAL
Enrollment

535

Participants

Timeline

Start Date

April 9, 2024

Primary Completion Date

May 22, 2024

Study Completion Date

September 30, 2024

Conditions
Chronic Kidney Disease stage4Chronic Kidney Disease Stage 5
Interventions
DIAGNOSTIC_TEST

Evolution of renal function

Plasma creatinine levels and glomerular filtration rate estimated using the CKD-Epi formula adjusted for 1.73 m2 body surface area will be measured.

DIAGNOSTIC_TEST

Measurement of haemoglobin levels

Haemoglobin levels will be measured.

DIAGNOSTIC_TEST

Measurement of biological parameters

Plasma levels of urea, calcium, phosphorus and parathyroid hormone, as well as alkaline reserve, will be measured.

DIAGNOSTIC_TEST

Measure sodium and protein consumption

24-hour urine volume, proteinuria, urea and sodium, will be measured.

BEHAVIORAL

Quality of life questionnaire EUROQOL 5 dimensions (EQ-5D-5L)

"The descriptive system comprises five dimensions: mobility, personal care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, mild problems, moderate problems, severe problems and extreme problems. The figures for the five dimensions can be combined into a 5-digit number describing the patient's state of health. Scores close to 1 indicate the best health you can imagine and those close to 0 the worst health you can imagine."

Trial Locations (1)

Unknown

AURA Santé, Chamalières

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT06495385 - Evaluation of a Multidisciplinary Care Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease | Biotech Hunter | Biotech Hunter